Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christos E. Emmanouilides, MD
Jonsson Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Chedoke-Mcmaster Hospitals
Hamilton, Ontario, Canada
- Huddinge University Hospital
Stockholm, Sweden
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- Arizona Cancer Center
Tucson, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Marlene and Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Tuft-New England Medical Center
Boston, Massachusetts, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Barrett Cancer Center
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2001
- Primary completion
- 30 Apr 2003
- Completion
- —
- Last update posted
- 8 Jan 2013
- Registered enrollment
- 7
- Registry id
- NCT00020800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.